Fructose-1,6-diphosphate: Potential protection in cyclosporine-lnduced renal impairment

Nephron

Volumn 72, Issue 1, 1996, Pages 67-71

  Cardoso, L R ^a   Santos, O F P ^b   Boiin, M A ^b   Barros, E G ^c   Ajzen, H ^b   Schor, N ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

6 diphosphate; Acute renal failure; Cyclosporine; Fructose 1; Glomeruli; Nephrotoxicity

Indexed keywords

CYCLOSPORIN; FRUCTOSE 1,6 BISPHOSPHATE; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; KIDNEY CLEARANCE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CYCLOSPORINE; FRUCTOSEDIPHOSPHATES; GLOMERULAR FILTRATION RATE; ISCHEMIA; KIDNEY; MALE; RATS; RATS, WISTAR; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 0030030585     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188808     Document Type: Article

References (36)

1. Kalian BD: Cyclosporine: The agent and its action. Transplant Proc 1985:17:5-18.
2. Barros EJG. Bonn MA. Ajzen H. Ramos OL, Schor N: Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 1987:32:19-25.
3. Mohaupt M, Kramer HJ: Acute renal failure: Review of experimental studies on pathophysiology and potential protective interventions. Ren Fail 1990;11:177-185.
4. Didlakc RM. Kirchner KA. Lewin J. Bower JD, Markov A: Protection from ischemic renal injury by fructose-1.6-diphosphate infusion in the rat. Circ Shock 1985; 16:205.
5. Markov AK, Terry J. White TZ. Didlake RH. llellens HK: Increasing survival of dogs subjected to haemorrhagic shock by administration of fructose 1,6 diphosphate. Surgery 1987;102:515-527.
6. Markov AK. Don Turner M. Oglethorpe N, Neely WA. Hellems HK: Fructose-1,6-diphosphate: An agent for treatment of experimental endotoxin shock. Surgery 1981:90:482-488.
7. Farias LA. Smith EE, Markov AK: Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose 1,6 diphosphate. Stroke 1990;21:606-613.
8. Sun JX, Farias LA. Markov AK: Fructose 1.6 diphosphate prevents intestinal ischemic re-perfusion injury and death in rats. Gastroenterology 1990:98:117-126.
9. Kirchner KA. Didlake R, Lewin J. Bower J. Markov A: Fructose 1.6 diphosphate administered after insult limits ischemic renal damage in the rat (abstract). Kidney Int 1984:24:233.
10. Markov AK: Hemodynamics and metabolic effects of fructosc-l.6-diphosphale in ischemia and shock-experimental and clinical observations. Ann Emcrg Med 1986:15:1470-1477.
11. Markov AK. Farias LA. Bennett WS. Subramo-ny C. Mihas AA: Prevention ofgalactosamine-induced hepatotoxicitv in rats with fructose 1,6 diphosphate. Pharmacology 1991:43:310-317.
12. Rao SB. Mehendale HM: Protection from chlordecone (Kepone)-potcntiatcd CC'I4 hepa-totoxicity in rats by fructose 1.6 diphosphate. Int J Biochcm 1989:21:949-954.
13. Danesi R. Bemardini N. Marchetli A. Bemar-dini M. DcITacca M: Protective effects of fructose 1.6 diphosphate on acute and chronic doxorubicin cardiotoxicity in rats. Cancer Che-mother Pharmacol 1990;25:326-332.
14. Ichikawa I. Maddox DA. Cogan MC. Brenner BM: Dynamics of glomerular ultrafiltration in euvolemic Munich-Westar rats. Ren Physiol 1978:1:121-131.
15. Fuhr J. Kaczmarczyc J. Kruttgen CD: Eine einfache colorimetrische Methode zur Inulin-Bestimmung für Nierenclearance-Untersuchun-gen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 1955:33:729-730.
16. Smith HW. Finkeistein N. Aluminosa L. Crawford B. Gräber M: The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
17. Boim MA. Ajzen H. Ramos OL. Schor N: Glomerular hemodynamics and hormonal evaluation during starvation in rats. Kidney Int 1992: 42:567-572.
18. Murray BM. Palier MS. Ferris TF: EfTecI of cyclosporine adminislration on renal hemodynamics in conscious rats. Kidney Int 1985:28: 767-774.
19. Mayers BD. Ross J. Newton L, Luelscher J. Perloth M: Cyclosporine-associated chronic nephropathy. N Engl J Med 1984:311:699-705.
20. Wallace AC: Histopathology of cyclosporine. Transplant Proc 1985; 17:117-122.
21. Bohman SO. Klimmalm G. Ringden O. Sunde-lin B. Wilkzek H: Interstitial fibrosis in human kidney grafts after 12 to 46 months of cyclosporine therapy. Transplant Proc 1985; 17:1168-1171.
22. Flcchner SM. Van Buren G. Herman RH, Kalian BD: The nephroloxicilv of cyclosporine in renal transplant recipients. Transplant Proc 1983;15:2689-2694.
23. Mihatsch MJ. RylTle B. Hermle M. Brunner FP, Thiel G: Morphology of cyclosporine nephrotoxicity in the rat. Clin Nephrol 1986:25:S2-S8.
24. Perico N. Zoja C. Bcnigni A. Delaini F. Re-muzzi G: Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporine A. Am J Physiol 1986:251: F58I-F587.
25. Edwards BS. Lloyd MA. Anderson EM: The synergistic effect of cyclosporine and endothe-lin-Demonstration of an important cardio-pressor action. Transplantation 1993:55:8-11.
26. Watschinger B, Ulrich W, Vvchytil A. Traindl O. Seidl S, Kainz H, Klauser R. Wämser P. Kovarik J: Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endothelium. Transplant Proc 1992: 24:2618-2619.
27. Takeda M. Fogo A. Kon V: Local endothelin activity is pivotal to endothelin pathophysiologic effects (abstract). 12th lilt Congr Nephrol, 1993. p 263.
28. Fogo A, Hellings SE, Inagami T. Kon V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 1992;42:770-774.
29. Copeland KR. Yatscoff RW: Comparison of the effects of cyclosporine and its metabolites on release of prostacyclin and endothelin from mesangial cells. Transplantation 1992:53:640-645.
30. Wagner K. Neumayer HH: Prevention of delayed graft function by diltiazem. a calcium antagonist, in recipients of cadaveric renal transplants treated with Sandimmun: 2 randomized studies. Lancet 1985 11:1355-1356.
31. Kirk AJ. Omar I. Dark JH: Long-term improvement in renal function using nefedipine in cyclosporine-associated hypertension. Transplantation 1990;50:1061.
32. Bilo HJG, StofT TJ, Korstanje MJ, Comans EFI. Donker AJM: Fish oil and renal function in cyclosporine-treated psoriasis patients (abstract). Kidney Int 1989:36:509.
33. Markov AK, Oglethorpe NC. Blake TM. Lehan PH. Hellems IIK: Hemodynamics, electrocardiographic and metabolic effects of fructose 1.6 diphosphate on acute myocardial ischemia. Am Heart J 1980:100:639-646.
34. De Torrcnte A. Miller PD, Cronin RE. Paulsin PE, Erickson AL. Schrier RW: Effects of furo-semide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol 1978: 235:F131-F136.
35. Didlake R. Kirchner KA. Lcwin J. Bower JD. Markov AK: Attenuation of ischemic renal injury with fructose 1,6 diphosphate. J Surg Res 1989:47:220-226.
36. Gudcr WG, Schmidt U: Substrate and oxygen dependence of renal metabolism. Kidnev Int 1976:10:S32-S38.